The active cases have further reduced to 31,29,878, comprising 12.14 per cent of the total infections, while the national COVID-19 recovery rate has improved to 86.74 per cent, the data updated at 8 am showed.
The national recovery rate is 93.94 per cent while the COVID-19 case fatality rate stands at 1.45 per cent.
Under the guidance of the India Council of Medical Research, three organisations -- National Institute of Occupational Health, Ahmedabad, National Institute of Nutrition, Hyderabad and the All India Institute of Medical Sciences -- will detect level of toxicity in toys that can be injurious to health.
The active cases comprise 0.04 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.75 per cent, the ministry said.
A total 16,577 infections were reported in a day, while the death toll increased to 1,56,825 with 120 new fatalities, the data updated at 8 am showed.
So far, less than 1 per cent of the target population of 77 crore in the 18-59 age group have been administered the precaution dose.
rediffGURU Maxim Emmanuel offers expert advice on how to make an informed career choice.
With 1,209 new deaths reported across the country, the toll due to the disease stands at 76,271.
There are 8,97,394 active cases of COVID-19, which is 20.53 per cent of the total caseload in the country, the data stated.
The COVID-19 case fatality rate due to the coronavirus infection stands at 1.7 per cent.
According to the Indian Council of Medical Research, 20,79,77,229 samples have so far been tested for the viral disease in the country, including 6,44,931 on Tuesday.
The death toll has climbed to 5,26,312 with 44 new fatalities, the data updated by the government at 8 am said.
The death toll climbed to 5,24,323 with 20 fresh fatalities, the data updated at 8 am stated.
A nasal vaccine, one expert said, is a "fantastic idea" for two reasons -- one, it can potentially create sterile immunity, and two, it is easy to administer and thus scalable.
The death toll climbed to 5,24,241 with 27 fresh fatalities, the data updated at 8 am stated.
The COVID-19 case fatality rate has declined to 1.84 per cent.
The active cases comprise 0.04 per cent of the total infections. The national COVID-19 recovery rate was recorded at 98.74 per cent, the ministry said.
India's COVID-19 tally climbed to 4,38,68,476 on Saturday with 21,411 fresh cases, while the number of active cases increased to 1,50,100, according to Union health ministry data.
The total cases of coronavirus infections mounted to 29,05,823, while the death toll climbed to 54,849 with 983 new fatalities being reported in a span of 24 hours, the data updated at 8 am showed.
A total of 74,91,513 people have recuperated from COVID-19 so far taking the national recovery rate to 91.54 per cent while the case fatality rate was recorded at 1.49 per cent.
With 13,052 new coronavirus infections being reported in a day, India's COVID-19 tally has gone up to 1,07,46,183, while the number of people who have recuperated from the disease has surged to 1,04,23,125, according to the Union health ministry data updated on Sunday.
India's active cases cases dipped to 20,403.
India has been reporting over 60,000 cases daily since August 7, barring August 11 when the country registered 53,601 new instances of the infection.
The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.
The active cases comprise 0.05 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.74 per cent, the ministry said.
The daily COVID-19 cases are being recorded at less than one lakh for the last six consecutive days.
India saw a single day rise of 58,077 coronavirus infections, which took the tally of cases to 4,25,36,137, while the active cases have declined to 6,97,802, according to Union health ministry data updated on Friday.
The officials of Indian Council of Medical Research (ICMR) also said there are now 1,065 testing labs in the country -- 768 in the public sector and 297 in private.
The active COVID-19 caseload of the country remained below two lakh for the fifth consecutive day.
While Maharashtra Home Minister Anil Deshmukh warned the yoga guru that the state government won't allow the sale of 'spurious' medicines, Rajasthan Health Minister Raghu Sharma also said that the state government will not allow the sale of Patanjali's Ayurvedic formulation.
Registering a steady increase for the 36th day in a row, the active cases have increased to 14,71,877 comprising 10.46 per cent of the total infections.
This is the seventh consecutive day that COVID-19 cases have increased by more than 50,000.
The active Covid cases have increased to 1,32,457. They comprise 0.30 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.49 per cent, the ministry said.
The active cases comprise 0.30 per cent of the total infections.
India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.
With this latest spike, the total cases in the country stand at 16,38,871.
The recovery rate among COVID-19 patients was recorded at 64.44 per cent, while the fatality rate was at 2.21 per cent.
The total coronavirus cases rose to 35,42,733, while the death toll climbed to 63,498 with 948 people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.
India logged 3,377 new COVID-19 infections taking the country's total tally of cases to 4,30,72,176, while the active cases rose to 17,801, according to the Union health ministry data updated on Friday.
Maharashtra Health Minister Rajesh Tope said the lowering of rates for the tests would provide a relief to the people.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances